Retension Pharmaceuticals, Inc. RTSN
12.08 USD -0.07 (-0.58%)
Nov 12, 2026, 10:49 AM EST
11.75 Day range 12.25
9.66 52-week range 18.64
- YTD
- +14.72%
- 1 year
- +14.72%
- Market cap
- 100.65M
- EPS (ttm)
- -2.61
- YTD return
- +14.72%
- 1-year return
- +14.72%
- Volume
- 33.65K
- Avg volume
- 149.25K
- Open
- 12.11
- Previous close
- 12.15
- Day's range
- 11.75 – 12.25
- 52-week range
- 9.66 – 18.64
5D +0.32 (+2.74%)
Financials — quick view
RTSN Revenue — annual 0
RTSN Net income — annual -6.30M
RTSN EPS — annual -1.26
News
Retension Pharmaceuticals to Participate in the Guggenheim 3rd Annual Healthcare Innovation Conference 
Oppenheimer Initiates Coverage On Retension Pharmaceuticals with Outperform Rating, Announces Price Target of $50 
Guggenheim Initiates Coverage On Retension Pharmaceuticals with Buy Rating, Announces Price Target of $55
Your note
Sign in to keep a note on RTSN — it syncs with the Stock Master app.